Table 6.
Expression of CD45RA and CD45RO isoforms in the CD8+ lymphocyte subset in controls and NBS patients
| Lymphocyte receptors | Control (C) n = 40 | NBS (A) n = 36 P1 | NBS (B) n = 7 P2 | P3 |
|---|---|---|---|---|
| CD45RA/CD8+ | ||||
| % (average ± s.d.) | 25 ± 4 | 20 ± 6 | 21 ± 8 | |
| CD45RA+ | ||||
| FI (geom. mean) | 12·4 | 15·7 | 13·4 | |
| CD8+ | < 10·9÷13·2 > | < 14·1÷17·3 > | < 11·1÷16·3 > | |
| FI | 42·9 | 18·6*** | 16·2*** | |
| < 40·7÷45·2 > | < 17·3÷20·2 > | < 14·6÷18·8 > | P = 0·12 | |
| Abs. cell count/mm3 (geom. mean) | 888 | 299** | 652*** | P = 0·05 |
| < 823÷959 > | < 251÷366 > | < 387÷1098 > | ||
| CD45RO/CD8+ | ||||
| % (average ± s.d.) | 3 ± 1 | 13 ± 7*** | 15 ± 3*** | P = 0·07 |
| CD45RO+ | ||||
| FI (geom. mean) | 3·4 | 6·9*** | 5·2*** | P = 0·09 |
| CD8+ | < 3·0÷3·7 > | < 6·3÷7·7 > | < 4·0÷6·8 > | |
| FI | 41·1 | 38·7 | 37·1 | |
| < 39·9÷43·1 > | < 36·4÷41·7 > | < 32·7÷41·9 > | ||
| Abs. cell count/mm3 (geom. mean) | 114 | 158*** | 466*** | P = 0·001 |
| < 106÷124 > | < 134÷186 > | < 282÷771 > | ||
| CD45RA/CD8+ | 8·8 | 1·8*** | 1·7*** | P = 0·65 |
| CD45RO/CD8+ ratio | < 7·9÷9·9 > | < 1·5÷2·1 > | < 1·2÷1·8 > | |